Research graph
References from Machine learning predicts relapse after anti-TNF withdrawal in ulcerative colitis using rectal biopsy transcriptomics. Local targets link to admitted publications; unresolved targets remain external evidence.
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment
10.1093/ecco-jcc/jjab178 · 2022 · External reference
10.1136/gutjnl-2019-320022
10.1136/gutjnl-2019-320022 · External reference
The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission
10.1016/s2468-1253(23)00003-1 · 2023 · External reference
10.1056/evidoa2200061
10.1056/evidoa2200061 · External reference
Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial
10.1016/s2468-1253(21)00062-5 · 2021 · External reference
Prediction of long-term remission in patients following discontinuation of anti-TNF therapy in ulcerative colitis: a 10 year follow up study
10.1186/s12876-022-02522-4 · 2022 · External reference
10.1136/gutjnl-2024-333385
10.1136/gutjnl-2024-333385 · External reference
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn’s disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial
10.1016/s2468-1253(22)00385-5 · 2023 · External reference
10.1093/bioinformatics/btl407
10.1093/bioinformatics/btl407 · External reference
10.1093/ibd/izab187
10.1093/ibd/izab187 · External reference
10.1093/ibd/izac115
10.1093/ibd/izac115 · External reference
10.1093/ecco-jcc/jjae197
10.1093/ecco-jcc/jjae197 · External reference
Anti-TNF withdrawal or long-term treatment in ulcerative colitis (BIOSTOP): a multicentre open label, randomized controlled trial
10.1093/ecco-jcc/jjag110 · 2026 · External reference
Full, Partial, and Modified Permutations of the Mayo Score: Characterizing Clinical and Patient-Reported Outcomes in Ulcerative Colitis Patients
10.1093/crocol/otab007 · 2021 · External reference
10.1056/nejm198712243172603
10.1056/nejm198712243172603 · External reference
10.1136/gutjnl-2015-310393
10.1136/gutjnl-2015-310393 · External reference
Longitudinal transcriptomic analysis of mucosa in ulcerative colitis after anti-tumor necrosis factor withdrawal compared to continued treatment
10.1093/ecco-jcc/jjag121 · 2026 · External reference
10.1038/s41587-020-0439-x
10.1038/s41587-020-0439-x · External reference
10.5281/zenodo.7598955
10.5281/zenodo.7598955 · External reference
10.1093/bioinformatics/bts635
10.1093/bioinformatics/bts635 · External reference
10.1038/nmeth.4197
10.1038/nmeth.4197 · External reference
10.1038/s41374-017-0005-4
10.1038/s41374-017-0005-4 · External reference
Aquaporin-8 expression is reduced in ileum and induced in colon of patients with ulcerative colitis
10.3748/wjg.v13.i11.1687 · 2007 · External reference
The value of mRNA expression of S100A8 and S100A9 as blood-based biomarkers of inflammatory bowel disease
10.1016/j.ajg.2019.07.002 · 2019 · External reference
10.1038/s41467-019-10769-x
10.1038/s41467-019-10769-x · External reference
10.1038/s41598-021-97366-5
10.1038/s41598-021-97366-5 · External reference
10.1016/j.cell.2019.06.029
10.1016/j.cell.2019.06.029 · External reference
Biomarkers prediction and immune landscape in ulcerative colitis: Findings based on bioinformatics and machine learning
10.1016/j.compbiomed.2023.107778 · 2024 · External reference
10.1038/nrgastro.2016.169
10.1038/nrgastro.2016.169 · External reference
10.1016/j.cell.2019.07.048
10.1016/j.cell.2019.07.048 · External reference
10.1016/j.cytogfr.2019.05.008
10.1016/j.cytogfr.2019.05.008 · External reference
LncRNA EPR controls epithelial proliferation by coordinating Cdkn1a transcription and mRNA decay response to TGF-β
10.1038/s41467-019-09754-1 · 2019 · External reference
10.1016/j.plipres.2022.101178
10.1016/j.plipres.2022.101178 · External reference
